title: Clinical scenario 2: Exploring treatment options for patients with symptomatic, progressive GEP-NETs.
authors.affiliation: Charité University Hospital, Berlin, Germany.
authors.forename: Ulrich-Frank
authors.initials: UF
authors.lastname: Pape
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism; D002276:Carcinoid Tumor / Q000175:diagnosis / Q000378:metabolism / Q000556:secondary* / Q000628:therapy; D005260:Female; D006801:Humans; D007414:Intestinal Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D008113:Liver Neoplasms / Q000175:diagnosis / Q000378:metabolism / Q000556:secondary* / Q000628:therapy; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D008875:Middle Aged; D010456:Peptides, Cyclic / Q000627:therapeutic use; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin